Titan Partners Group, a division of American Capital Partners, has launched its Equity Research Division by appointing Dr. Boris Peaker as managing director and senior equity research analyst. Dr. Peaker brings 17 years of specialized experience in healthcare equity research, with a particular focus on the biotechnology sector.
Jason Sands, co-founder and partner at Titan, highlighted the strategic significance of this appointment, emphasizing the firm's commitment to building research capabilities around fundamentally strong and scientifically compelling investment narratives. Dr. Peaker's extensive background and reputation in healthcare equity research align closely with Titan's strategic objectives.
The addition of a dedicated equity research platform represents a significant milestone for Titan Partners Group. By bringing Dr. Peaker on board, the firm is positioning itself to provide more sophisticated and targeted research insights in the healthcare and biotechnology domains.
This expansion signals Titan's intention to strengthen its investment banking services and offer more comprehensive advisory solutions to emerging growth companies. The new research division is expected to enhance the firm's ability to identify and analyze investment opportunities in complex and innovative sectors.
